Cardiac and Critical Care Division, Great Ormond Street Hospital National Health Service Foundation Trust, London, United Kingdom.
Population, Policy and Practice Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
J Thorac Cardiovasc Surg. 2019 Oct;158(4):1185-1196.e7. doi: 10.1016/j.jtcvs.2019.03.139. Epub 2019 Jun 12.
Given excellent 30-day survival for pediatric cardiac surgery, other outcome measures are important. We aimed to study important early postoperative morbidities selected by stakeholders following a rigorous and evidenced-based process, with a view to identifying potential risk factors.
The incidence of selected morbidities was prospectively measured for 3090 consecutive pediatric cardiac surgical admissions in 5 UK centers between October 2015 and June 2017. The relationship between the candidate risk factors and the incidence of morbidities was explored using multiple regressions. Patient survival, a secondary outcome, was checked at 6 months.
A total of 675 (21.8%) procedure episodes led to at least 1 of the following: acute neurologic event, unplanned reoperation, feeding problems, renal replacement therapy, major adverse events, extracorporeal life support, necrotizing enterocolitis, surgical infection, or prolonged pleural effusion. The highest adjusted odds ratio of morbidity was in neonates compared with children, 5.26 (95% confidence interval, 3.90-7.06), and complex heart diseases (eg, hypoplastic left heart), 2.14 (95% confidence interval, 1.41-3.24) compared with low complexity (eg, atrial septal defect, P < .001 for all). Patients with any selected morbidity had a 6-month survival of 88.2% (95% confidence interval, 85.4-90.6) compared with 99.3% (95% confidence interval, 98.9-99.6) with no defined morbidity (P < .001).
Evaluation of postoperative morbidity provides important information over and above 30-day survival and should become a focus for audit and quality improvement. Our results have been used to initiate UK-based audit for 5 of these 9 morbidities, co-develop software for local monitoring of these morbidities, and parent information about these morbidities.
鉴于儿科心脏手术 30 天生存率非常高,其他结果衡量指标也很重要。我们旨在通过严格的循证过程,研究由利益攸关方选择的重要术后早期并发症,并以此来确定潜在的风险因素。
2015 年 10 月至 2017 年 6 月,在英国的 5 个中心,对 3090 例连续的儿科心脏手术入院患者前瞻性地测量了选定的并发症发生率。使用多元回归分析探讨候选风险因素与并发症发生率之间的关系。次要结果是 6 个月时的患者存活率。
共有 675 例(21.8%)手术出现以下至少 1 种情况:急性神经系统事件、计划外再次手术、喂养问题、肾脏替代治疗、重大不良事件、体外生命支持、坏死性小肠结肠炎、手术感染或持续性胸腔积液。与儿童相比,新生儿的发病率最高,调整后的优势比为 5.26(95%置信区间,3.90-7.06);与低复杂性疾病(如房间隔缺损)相比,复杂性心脏病(如左心发育不全)的调整后优势比为 2.14(95%置信区间,1.41-3.24),差异均有统计学意义(所有 P 值均<.001)。发生任何选定并发症的患者 6 个月存活率为 88.2%(95%置信区间,85.4-90.6),而无定义并发症的患者存活率为 99.3%(95%置信区间,98.9-99.6),差异有统计学意义(P<.001)。
评估术后发病率除了 30 天生存率之外,还提供了重要信息,应成为审核和质量改进的重点。我们的研究结果已用于启动英国针对这 9 种并发症中的 5 种并发症的审核,共同开发用于监测这些并发症的本地软件,并向患儿家长提供这些并发症的相关信息。